Treatment of bleeding following cardiopulmonary bypass in neonates and infants

1993 ◽  
Vol 3 (3) ◽  
pp. 257-262 ◽  
Author(s):  
Wulf Dietrich ◽  
Hansjörg J. Mössinger ◽  
Josef A. Richter

Bleeding after cardiopulmonary bypass remains a significant problem for the cardiac surgeon. In addition to surgically-induced bleeding, the major cause of loss of blood is an acquired coagulopathy. Impaired function, produced either by the mechanical effect of cardiopulmonary bypass or by the influence of hemostatic activation of platelets during bypass, is the main cause of postoperative bleeding. The tendency towards bleeding in infants and neonates is additionally influenced by the type of operation, those with cyanotic heart disease demonstrating an increased tendency to bleeding. Most of the procedures are more complex than in adults, and many reoperations are necessary, particularly if primary correction is not possible. Furthermore, procedures for perfusion and cooling are mostly different from those used in adults. The operations are regularly performed using deep hypothermia or circulatory arrest, which may further impair the function of platelets. Yet the effect of low temperatures on hemostasis, with or without circulatory arrest, still remains unclear, since the immature system for coagulation in neonates may contribute to impaired hemostasis.

Critical Care ◽  
10.1186/cc334 ◽  
1999 ◽  
Vol 3 (S2) ◽  
Author(s):  
H Abdul- Khaliq ◽  
LE Blasig ◽  
MO Baur ◽  
M Hohlfeld ◽  
V Alexi-Meskheshvili ◽  
...  

2009 ◽  
Vol 29 (5) ◽  
pp. 886-890 ◽  
Author(s):  
Wei Yang ◽  
Qing Ma ◽  
G Burkhard Mackensen ◽  
Wulf Paschen

Various cardiovascular operations are performed during conditions of deep hypothermic circulatory arrest. Here we investigated the effects of deep hypothermia on the small ubiquitin-like modifier (SUMO) conjugation pathway using a clinically relevant animal model of deep hypothermic cardiopulmonary bypass (DHCPB). Deep hypothermic cardiopulmonary bypass induced a marked activation of the SUMO conjugation pathway and triggered a nuclear translocation of SUMO2/3-conjugated proteins. Furthermore, DHCBP significantly modified gene expression. Activation of the SUMO conjugation pathway is believed to protect neurons from damage caused by low blood flow. This pathway may, therefore, play a key role in defining the outcome of cells exposed to DHCPB.


1972 ◽  
Vol 64 (3) ◽  
pp. 422-429 ◽  
Author(s):  
Atsumi Mori ◽  
Ryusuke Muraoka ◽  
Yoshio Yokota ◽  
Yoshijumi Okamoto ◽  
Fumitaka Ando ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document